Patent Assignment
Reel/Frame 044680/0739
Change of Name
Recorded: 2017-11-02
Pages: 3
Assignor
KALABIOS PHARMACEUTICALS, INC.
Executed: 2017-07-21
Assignee
HUMANIGEN, INC.
1000 MARINA BOULEVARD, SUITE 250, BRISBANE, CALIFORNIA, 94005-1878
Covered Property
(1)
Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3
Application:
15/265,625 →
Publication:
US 2017/0226227
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Assignment of Assignor's Interest
Nov 1, 2017
From: BEBBINGTON, CHRISTOPHER R.; YARRANTON, GEOFFREY T.; PALATH, VARGHESE
To: KALOBIOS PHARMACEUTICALS INC.
Reel/Frame 044011/0402 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →